Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Drug developers are constantly looking for innovative strategies and technologies to improve drug discovery and speed up development in a cost effective and timely manner.

This publication from Stanford University delves into how one increasingly popular strategy, drug repositioning, can identify new uses of old drugs efficiently. Drug discovery is being applied through a computational approach to discover new drug therapies using publically available data.

The findings of this research support using publically available molecular data and computational approaches to discover new therapeutics operations for a disease. As a systematic drug discovery strategy, it may be a new discipline for many but it is also one that is promising much for an industry striving to innovate.